SIMILAR PATTERNS OF AMINO ACIDS FOR 3JW2_A_017A401_2

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1aug PYROGLUTAMYL
PEPTIDASE-1


(Bacillus
amyloliquefaciens)
PF01470
(Peptidase_C15)
6 LEU A   7
ALA A 200
ILE A 119
ILE A 195
VAL A  69
ILE A  67
None
1.38A 3jw2B-1augA:
0.0
3jw2B-1augA:
18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bou 4,5-DIOXYGENASE BETA
CHAIN


(Sphingomonas
paucimobilis)
PF02900
(LigB)
6 LEU B  16
GLY B 274
ALA B 275
ILE B   8
GLY B 189
VAL B 131
None
1.02A 3jw2B-1bouB:
undetectable
3jw2B-1bouB:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1czi CHYMOSIN

(Bos taurus)
PF00026
(Asp)
5 ASP E 215
GLY E 217
VAL E 222
GLY E  76
ILE E 300
None
0.80A 3jw2B-1cziE:
6.6
3jw2B-1cziE:
19.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1czi CHYMOSIN

(Bos taurus)
PF00026
(Asp)
5 LEU E  30
ASP E  32
GLY E  34
ASP E  37
ILE E 120
None
0.65A 3jw2B-1cziE:
6.6
3jw2B-1cziE:
19.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1e1t LYSYL-TRNA
SYNTHETASE, HEAT
INDUCIBLE


(Escherichia
coli)
PF00152
(tRNA-synt_2)
PF01336
(tRNA_anti-codon)
6 LEU A 326
ALA A 379
ASP A 376
GLY A 419
ILE A 384
ILE A 389
None
None
None
None
GOL  A 609 ( 3.9A)
None
1.39A 3jw2B-1e1tA:
0.0
3jw2B-1e1tA:
12.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ex6 GUANYLATE KINASE

(Saccharomyces
cerevisiae)
PF00625
(Guanylate_kin)
6 ALA A 174
ASP A 170
ASP A 169
VAL A 167
GLY A  13
ILE A 166
None
1.42A 3jw2B-1ex6A:
undetectable
3jw2B-1ex6A:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fob BETA-1,4-GALACTANASE

(Aspergillus
aculeatus)
PF07745
(Glyco_hydro_53)
6 GLY A  40
ALA A  39
ASP A  38
VAL A 324
ILE A  44
ILE A 328
None
1.06A 3jw2B-1fobA:
undetectable
3jw2B-1fobA:
13.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gpe PROTEIN (GLUCOSE
OXIDASE)


(Penicillium
amagasakiense)
PF00732
(GMC_oxred_N)
PF05199
(GMC_oxred_C)
6 LEU A 302
GLY A 294
ALA A 293
VAL A 254
ILE A 551
ILE A 301
None
FAD  A 600 ( 3.8A)
FAD  A 600 (-3.6A)
FAD  A 600 (-4.0A)
None
None
1.33A 3jw2B-1gpeA:
undetectable
3jw2B-1gpeA:
9.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gz5 ALPHA-TREHALOSE-PHOS
PHATE SYNTHASE


(Escherichia
coli)
PF00982
(Glyco_transf_20)
5 GLY A 389
ALA A 390
ILE A 434
GLY A 226
ILE A 225
None
None
None
None
IMD  A 902 ( 4.3A)
0.84A 3jw2B-1gz5A:
undetectable
3jw2B-1gz5A:
15.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ALA A  28
ASP A  29
ASP A  30
ILE A  84
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 (-3.8A)
A79  A 800 (-3.6A)
1.17A 3jw2B-1hvcA:
13.9
3jw2B-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ALA A  28
ASP A  29
ASP A  30
ILE A  84
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 (-3.6A)
A79  A 800 (-3.8A)
1.24A 3jw2B-1hvcA:
13.9
3jw2B-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  48
VAL A  82
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-4.1A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.86A 3jw2B-1hvcA:
13.9
3jw2B-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 (-3.6A)
1.25A 3jw2B-1hvcA:
13.9
3jw2B-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 (-3.8A)
1.27A 3jw2B-1hvcA:
13.9
3jw2B-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
VAL A  82
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.48A 3jw2B-1hvcA:
13.9
3jw2B-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
VAL A  82
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.3A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.46A 3jw2B-1hvcA:
13.9
3jw2B-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  48
VAL A  82
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.4A)
A79  A 800 (-3.6A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.86A 3jw2B-1hvcA:
13.9
3jw2B-1hvcA:
46.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ij9 VASCULAR CELL
ADHESION PROTEIN 1


(Homo sapiens)
PF05790
(C2-set)
PF07679
(I-set)
6 LEU A 169
ALA A 189
ASP A  94
ILE A 126
VAL A 111
ILE A  97
None
1.32A 3jw2B-1ij9A:
undetectable
3jw2B-1ij9A:
17.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kcx DIHYDROPYRIMIDINASE
RELATED PROTEIN-1


(Mus musculus)
PF01979
(Amidohydro_1)
6 GLY A  46
ALA A  33
ASP A  34
VAL A  65
ILE A  19
ILE A  24
None
1.37A 3jw2B-1kcxA:
undetectable
3jw2B-1kcxA:
11.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1l8w VLSE1

(Borreliella
burgdorferi)
PF00921
(Lipoprotein_2)
5 GLY A 221
ALA A 222
ASP A 277
GLY A 197
ILE A 284
None
0.82A 3jw2B-1l8wA:
undetectable
3jw2B-1l8wA:
16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1llu ALCOHOL
DEHYDROGENASE


(Pseudomonas
aeruginosa)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 GLY A  42
ILE A  64
GLY A 119
VAL A  36
ILE A  38
None
0.72A 3jw2B-1lluA:
undetectable
3jw2B-1lluA:
15.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mro METHYL-COENZYME M
REDUCTASE


(Methanothermobacter
marburgensis)
PF02249
(MCR_alpha)
PF02745
(MCR_alpha_N)
6 LEU A 120
VAL A 124
ILE A 129
ILE A 231
VAL A 115
ILE A 116
None
1.23A 3jw2B-1mroA:
undetectable
3jw2B-1mroA:
11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1naa CELLOBIOSE
DEHYDROGENASE


(Phanerochaete
chrysosporium)
PF00732
(GMC_oxred_N)
PF05199
(GMC_oxred_C)
6 LEU A 475
GLY A 467
ALA A 466
VAL A 428
ILE A 463
ILE A 474
None
6FA  A 801 (-3.3A)
6FA  A 801 (-3.4A)
6FA  A 801 (-4.0A)
None
None
1.11A 3jw2B-1naaA:
undetectable
3jw2B-1naaA:
11.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q7h CONSERVED
HYPOTHETICAL PROTEIN


(Thermoplasma
acidophilum)
PF01472
(PUA)
PF09183
(DUF1947)
6 ALA A 137
VAL A  73
ILE A 101
GLY A 127
VAL A  95
ILE A  94
None
1.33A 3jw2B-1q7hA:
undetectable
3jw2B-1q7hA:
17.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
None
0.46A 3jw2B-1q9pA:
10.4
3jw2B-1q9pA:
98.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rcq CATABOLIC ALANINE
RACEMASE DADX


(Pseudomonas
aeruginosa)
PF00842
(Ala_racemase_C)
PF01168
(Ala_racemase_N)
5 GLY A 315
ALA A 314
ILE A 265
VAL A 286
ILE A 288
None
0.82A 3jw2B-1rcqA:
undetectable
3jw2B-1rcqA:
14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s2t PHOSPHOENOLPYRUVATE
PHOSPHOMUTASE


(Mytilus edulis)
PF13714
(PEP_mutase)
5 LEU A  71
ALA A  32
GLY A  42
ILE A  23
VAL A 108
None
0.82A 3jw2B-1s2tA:
undetectable
3jw2B-1s2tA:
18.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
None
1.27A 3jw2B-1sivA:
18.3
3jw2B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
None
0.47A 3jw2B-1sivA:
18.3
3jw2B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  84
None
0.83A 3jw2B-1sivA:
18.3
3jw2B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 LEU A  24
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  22
None
1.49A 3jw2B-1sivA:
18.3
3jw2B-1sivA:
50.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tlg POLYANDROCARPA
LECTIN


(Polyandrocarpa
misakiensis)
PF00059
(Lectin_C)
5 LEU A  81
GLY A  56
ALA A  57
ASP A  58
GLY A  72
None
0.83A 3jw2B-1tlgA:
undetectable
3jw2B-1tlgA:
17.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1to3 PUTATIVE ALDOLASE
YIHT


(Salmonella
enterica)
PF01791
(DeoC)
6 LEU A 184
GLY A 188
ALA A 189
ASP A 190
VAL A 127
ILE A 158
None
0.88A 3jw2B-1to3A:
undetectable
3jw2B-1to3A:
16.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1usy ATP
PHOSPHORIBOSYLTRANSF
ERASE REGULATORY
SUBUNIT


(Thermotoga
maritima)
PF13393
(tRNA-synt_His)
5 ALA C 251
VAL C 114
ILE C 238
VAL C 109
ILE C 113
None
0.65A 3jw2B-1usyC:
undetectable
3jw2B-1usyC:
15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vrg PROPIONYL-COA
CARBOXYLASE, BETA
SUBUNIT


(Thermotoga
maritima)
PF01039
(Carboxyl_trans)
6 GLY A 416
ALA A 417
ASP A 418
ILE A 395
ILE A 346
VAL A 360
None
1.28A 3jw2B-1vrgA:
undetectable
3jw2B-1vrgA:
13.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1x0u HYPOTHETICAL
METHYLMALONYL-COA
DECARBOXYLASE ALPHA
SUBUNIT


(Sulfurisphaera
tokodaii)
PF01039
(Carboxyl_trans)
6 GLY A 424
ALA A 425
ASP A 426
ILE A 403
ILE A 354
VAL A 368
None
1.32A 3jw2B-1x0uA:
undetectable
3jw2B-1x0uA:
12.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xr4 PUTATIVE CITRATE
LYASE ALPHA
CHAIN/CITRATE-ACP
TRANSFERASE


(Salmonella
enterica)
PF04223
(CitF)
6 GLY A 384
VAL A 487
ILE A 128
GLY A 125
VAL A 490
ILE A 501
None
1.47A 3jw2B-1xr4A:
undetectable
3jw2B-1xr4A:
12.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yya TRIOSEPHOSPHATE
ISOMERASE


(Thermus
thermophilus)
PF00121
(TIM)
6 GLY A   8
ALA A   7
VAL A 162
GLY A 210
VAL A  92
ILE A 123
None
1.37A 3jw2B-1yyaA:
undetectable
3jw2B-1yyaA:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2b4q RHAMNOLIPIDS
BIOSYNTHESIS
3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
REDUCTASE


(Pseudomonas
aeruginosa)
PF13561
(adh_short_C2)
6 GLY A 237
ALA A 236
VAL A  90
ILE A  25
GLY A  28
ILE A  88
None
1.04A 3jw2B-2b4qA:
undetectable
3jw2B-2b4qA:
19.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bc0 NADH OXIDASE

(Streptococcus
pyogenes)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 GLY A 453
ALA A 454
ASP A 456
ILE A 387
ILE A 426
None
0.64A 3jw2B-2bc0A:
undetectable
3jw2B-2bc0A:
12.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bii NITRATE REDUCTASE
[NADPH]


(Ogataea angusta)
PF00174
(Oxidored_molyb)
PF03404
(Mo-co_dimer)
5 LEU A 256
GLY A 178
ALA A 180
VAL A 107
ILE A 109
None
0.82A 3jw2B-2biiA:
undetectable
3jw2B-2biiA:
13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dph FORMALDEHYDE
DISMUTASE


(Pseudomonas
putida)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
6 GLY A 174
ALA A 201
VAL A 189
GLY A 296
ILE A 297
ILE A 191
None
1.48A 3jw2B-2dphA:
undetectable
3jw2B-2dphA:
14.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eja UROPORPHYRINOGEN
DECARBOXYLASE


(Aquifex
aeolicus)
PF01208
(URO-D)
5 GLY A 192
ALA A 193
ASP A 194
ILE A 134
ILE A 120
None
0.82A 3jw2B-2ejaA:
undetectable
3jw2B-2ejaA:
14.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ewn BIRA BIFUNCTIONAL
PROTEIN


(Escherichia
coli)
PF02237
(BPL_C)
PF03099
(BPL_LplA_LipB)
PF08279
(HTH_11)
6 LEU A 131
GLY A 186
ALA A 185
GLY A 154
ILE A 153
ILE A 207
None
BTX  A 501 (-3.3A)
None
None
None
None
1.13A 3jw2B-2ewnA:
undetectable
3jw2B-2ewnA:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f5v PYRANOSE 2-OXIDASE

(Peniophora sp.
SG)
PF05199
(GMC_oxred_C)
6 LEU A 329
GLY A 321
ALA A 320
ILE A  77
ILE A  51
VAL A 286
None
FAD  A1625 ( 3.9A)
FAD  A1625 (-3.6A)
FAD  A1625 (-3.9A)
None
None
1.49A 3jw2B-2f5vA:
undetectable
3jw2B-2f5vA:
11.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  55
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
1.33A 3jw2B-2fmbA:
14.9
3jw2B-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
VAL A  87
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.87A 3jw2B-2fmbA:
14.9
3jw2B-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
VAL A  87
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.45A 3jw2B-2fmbA:
14.9
3jw2B-2fmbA:
33.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ggq 401AA LONG
HYPOTHETICAL
GLUCOSE-1-PHOSPHATE
THYMIDYLYLTRANSFERAS
E


(Sulfurisphaera
tokodaii)
PF00132
(Hexapep)
PF00483
(NTP_transferase)
6 LEU A 355
VAL A 375
ILE A 377
GLY A 360
ILE A  17
VAL A 341
None
1.34A 3jw2B-2ggqA:
undetectable
3jw2B-2ggqA:
14.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hk7 SHIKIMATE
DEHYDROGENASE


(Aquifex
aeolicus)
PF01488
(Shikimate_DH)
PF08501
(Shikimate_dh_N)
6 GLY A 146
ALA A 147
VAL A 183
ILE A 118
VAL A 128
ILE A 126
None
1.08A 3jw2B-2hk7A:
undetectable
3jw2B-2hk7A:
17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ilu ALDEHYDE
DEHYDROGENASE A


(Escherichia
coli)
PF00171
(Aldedh)
6 ALA A  46
ASP A  45
ILE A  11
ILE A 175
VAL A 145
ILE A  50
None
1.27A 3jw2B-2iluA:
undetectable
3jw2B-2iluA:
14.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iss PYRIDOXAL
BIOSYNTHESIS LYASE
PDXS


(Thermotoga
maritima)
PF01680
(SOR_SNZ)
5 LEU A 224
GLY A 229
ALA A 230
ASP A 231
VAL A 158
None
0.82A 3jw2B-2issA:
undetectable
3jw2B-2issA:
14.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iwz 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
SYNTHASE


(Homo sapiens)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
6 LEU A 454
GLY A 234
ALA A 233
GLY A  48
ILE A  49
VAL A 302
None
1.32A 3jw2B-2iwzA:
undetectable
3jw2B-2iwzA:
13.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jfd FATTY ACID SYNTHASE

(Homo sapiens)
PF00698
(Acyl_transf_1)
PF16197
(KAsynt_C_assoc)
6 LEU A 567
ALA A 590
ASP A 591
GLY A 579
ILE A 495
ILE A 564
None
1.31A 3jw2B-2jfdA:
undetectable
3jw2B-2jfdA:
14.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2kl5 UNCHARACTERIZED
PROTEIN YUTD


(Bacillus
subtilis)
PF06265
(DUF1027)
6 LEU A  22
GLY A  29
ASP A  52
VAL A  50
ILE A  84
VAL A  23
None
1.42A 3jw2B-2kl5A:
undetectable
3jw2B-2kl5A:
24.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ma4 PUTATIVE PERIPLASMIC
PROTEIN


(Salmonella
enterica)
PF07338
(DUF1471)
6 ASP A  57
VAL A  70
ILE A  43
GLY A  83
ILE A  81
ILE A  24
None
1.37A 3jw2B-2ma4A:
undetectable
3jw2B-2ma4A:
20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2o7q BIFUNCTIONAL
3-DEHYDROQUINATE
DEHYDRATASE/SHIKIMAT
E DEHYDROGENASE


(Arabidopsis
thaliana)
PF01487
(DHquinase_I)
PF01488
(Shikimate_DH)
PF08501
(Shikimate_dh_N)
5 GLY A 236
ALA A 237
ASP A 238
ILE A 210
ILE A 232
None
0.74A 3jw2B-2o7qA:
undetectable
3jw2B-2o7qA:
12.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p50 N-ACETYLGLUCOSAMINE-
6-PHOSPHATE
DEACETYLASE


(Escherichia
coli)
PF01979
(Amidohydro_1)
6 LEU A 184
ALA A 163
ASP A 164
GLY A 127
VAL A 191
ILE A 189
None
1.25A 3jw2B-2p50A:
undetectable
3jw2B-2p50A:
14.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ph3 3-OXOACYL-[ACYL
CARRIER PROTEIN]
REDUCTASE


(Thermus
thermophilus)
PF13561
(adh_short_C2)
6 LEU A  28
GLY A  14
ALA A   9
VAL A  56
VAL A  54
ILE A  30
None
1.11A 3jw2B-2ph3A:
undetectable
3jw2B-2ph3A:
17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q0l THIOREDOXIN
REDUCTASE


(Helicobacter
pylori)
PF07992
(Pyr_redox_2)
5 ALA A   5
VAL A  84
ILE A 108
GLY A   8
ILE A  93
None
None
None
FAD  A 400 (-3.2A)
None
0.83A 3jw2B-2q0lA:
undetectable
3jw2B-2q0lA:
16.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q50 GLYOXYLATE
REDUCTASE/HYDROXYPYR
UVATE REDUCTASE


(Homo sapiens)
PF00389
(2-Hacid_dh)
PF02826
(2-Hacid_dh_C)
6 GLY A  72
ALA A  71
VAL A  63
ILE A  78
GLY A  54
ILE A  67
None
1.38A 3jw2B-2q50A:
undetectable
3jw2B-2q50A:
17.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q5e CARBOXY-TERMINAL
DOMAIN RNA
POLYMERASE II
POLYPEPTIDE A SMALL
PHOSPHATASE 2


(Homo sapiens)
PF03031
(NIF)
6 GLY A 257
ALA A 258
ASP A 260
ILE A 251
VAL A 104
ILE A 102
None
1.39A 3jw2B-2q5eA:
undetectable
3jw2B-2q5eA:
19.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qjg PUTATIVE ALDOLASE
MJ0400


(Methanocaldococcus
jannaschii)
PF01791
(DeoC)
5 LEU A 174
GLY A 179
ALA A 180
ASP A 181
ILE A 149
None
0.67A 3jw2B-2qjgA:
undetectable
3jw2B-2qjgA:
14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ri6 2-HYDROXY-6-OXO-6-PH
ENYLHEXA-2,4-DIENOAT
E HYDROLASE


(Paraburkholderia
xenovorans)
PF12697
(Abhydrolase_6)
6 LEU A 283
GLY A  63
ALA A  62
GLY A  57
VAL A 279
ILE A 280
None
1.00A 3jw2B-2ri6A:
undetectable
3jw2B-2ri6A:
15.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  84
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 4.2A)
1.23A 3jw2B-2rkfA:
20.4
3jw2B-2rkfA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
1.33A 3jw2B-2rkfA:
20.4
3jw2B-2rkfA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 ( 4.2A)
0.42A 3jw2B-2rkfA:
20.4
3jw2B-2rkfA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  84
None
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.89A 3jw2B-2rkfA:
20.4
3jw2B-2rkfA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
6 LEU A  35
ASP A  37
ALA A  40
ASP A  41
ILE A  71
ILE A 108
None
1.31A 3jw2B-2rspA:
12.7
3jw2B-2rspA:
32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
6 LEU A  35
ASP A  37
GLY A  39
ALA A  40
ASP A  41
ILE A 108
None
0.31A 3jw2B-2rspA:
12.7
3jw2B-2rspA:
32.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2v0j BIFUNCTIONAL PROTEIN
GLMU


(Haemophilus
influenzae)
PF00132
(Hexapep)
PF12804
(NTP_transf_3)
6 LEU A 201
GLY A 171
VAL A 149
ILE A 142
GLY A 140
ILE A 202
None
1.32A 3jw2B-2v0jA:
undetectable
3jw2B-2v0jA:
12.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vn8 RETICULON-4-INTERACT
ING PROTEIN 1


(Homo sapiens)
PF08240
(ADH_N)
PF13602
(ADH_zinc_N_2)
5 LEU A 243
GLY A 248
ALA A 249
ASP A 250
ASP A 251
None
0.77A 3jw2B-2vn8A:
undetectable
3jw2B-2vn8A:
15.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vvg KINESIN-2

(Giardia
intestinalis)
PF00225
(Kinesin)
5 LEU A 307
ASP A 241
ILE A 117
GLY A 115
ILE A  93
None
MG  A1352 ( 4.1A)
None
None
None
0.82A 3jw2B-2vvgA:
undetectable
3jw2B-2vvgA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y23 MYOMESIN

(Homo sapiens)
PF07679
(I-set)
5 ASP A1401
GLY A1409
ILE A1410
VAL A1428
ILE A1389
None
0.78A 3jw2B-2y23A:
undetectable
3jw2B-2y23A:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yb6 UBIQUITIN-CONJUGATIN
G ENZYME E2 B


(Homo sapiens)
PF00179
(UQ_con)
5 GLY A  26
ALA A  38
VAL A  70
ILE A 109
ILE A  57
None
0.84A 3jw2B-2yb6A:
undetectable
3jw2B-2yb6A:
20.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z5x AMINE OXIDASE
[FLAVIN-CONTAINING]
A


(Homo sapiens)
PF01593
(Amino_oxidase)
5 LEU A 233
ALA A  29
VAL A 238
GLY A  22
ILE A  23
None
None
None
FAD  A 600 (-3.2A)
FAD  A 600 (-4.9A)
0.81A 3jw2B-2z5xA:
undetectable
3jw2B-2z5xA:
13.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a9v 4-COUMARATE--COA
LIGASE


(Populus
tomentosa)
PF00501
(AMP-binding)
PF13193
(AMP-binding_C)
6 LEU A  41
GLY A 249
ALA A 250
ASP A 224
ILE A 274
ILE A 252
None
1.31A 3jw2B-3a9vA:
undetectable
3jw2B-3a9vA:
9.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ag6 PANTOTHENATE
SYNTHETASE


(Staphylococcus
aureus)
PF02569
(Pantoate_ligase)
6 LEU A  39
GLY A  87
ALA A  88
ASP A  89
ILE A  53
GLY A  26
None
1.39A 3jw2B-3ag6A:
undetectable
3jw2B-3ag6A:
14.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3aqc COMPONENT A OF
HEXAPRENYL
DIPHOSPHATE SYNTHASE


(Micrococcus
luteus)
no annotation 6 LEU A  95
ASP A  27
VAL A  48
ILE A  31
VAL A  43
ILE A  47
None
1.37A 3jw2B-3aqcA:
undetectable
3jw2B-3aqcA:
19.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b8b CYSQ, SULFITE
SYNTHESIS PATHWAY
PROTEIN


(Bacteroides
thetaiotaomicron)
PF00459
(Inositol_P)
6 ALA A   6
ASP A   5
VAL A 112
GLY A  11
ILE A  14
ILE A 100
None
1.25A 3jw2B-3b8bA:
undetectable
3jw2B-3b8bA:
15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c4a PROBABLE TRYPTOPHAN
HYDROXYLASE VIOD


(Chromobacterium
violaceum)
no annotation 6 LEU A 292
ALA A  11
ASP A 269
GLY A   7
ILE A  30
VAL A 265
None
FAD  A 401 (-3.4A)
FAD  A 401 (-2.8A)
FAD  A 401 (-3.6A)
None
None
1.33A 3jw2B-3c4aA:
undetectable
3jw2B-3c4aA:
14.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c4n UNCHARACTERIZED
PROTEIN DR_0571


(Deinococcus
radiodurans)
PF01266
(DAO)
5 LEU A 370
GLY A 200
VAL A  40
VAL A 230
ILE A 228
None
0.82A 3jw2B-3c4nA:
undetectable
3jw2B-3c4nA:
12.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3d79 PUTATIVE
UNCHARACTERIZED
PROTEIN PH0734


(Pyrococcus
horikoshii)
PF01472
(PUA)
PF09183
(DUF1947)
6 LEU A 101
GLY A  95
ALA A  96
VAL A 106
ILE A 111
ILE A 100
None
1.03A 3jw2B-3d79A:
undetectable
3jw2B-3d79A:
18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ecq ENDO-ALPHA-N-ACETYLG
ALACTOSAMINIDASE


(Streptococcus
pneumoniae)
PF12905
(Glyco_hydro_101)
PF17451
(Glyco_hyd_101C)
6 LEU A 360
GLY A 464
ALA A 465
ASP A 485
VAL A 542
VAL A 456
None
1.41A 3jw2B-3ecqA:
undetectable
3jw2B-3ecqA:
5.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eg4 2,3,4,5-TETRAHYDROPY
RIDINE-2,6-DICARBOXY
LATE
N-SUCCINYLTRANSFERAS
E


(Brucella suis)
PF00132
(Hexapep)
PF14602
(Hexapep_2)
PF14805
(THDPS_N_2)
6 LEU A 130
GLY A 144
ALA A 145
ILE A 185
VAL A 135
ILE A 147
None
1.27A 3jw2B-3eg4A:
undetectable
3jw2B-3eg4A:
17.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3f1x SERINE
ACETYLTRANSFERASE


(Bacteroides
vulgatus)
PF00132
(Hexapep)
6 LEU A 231
ALA A 264
VAL A 284
ILE A 294
ILE A 259
ILE A 266
None
1.27A 3jw2B-3f1xA:
undetectable
3jw2B-3f1xA:
15.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fgb UNCHARACTERIZED
PROTEIN Q89ZH8_BACTN


(Bacteroides
thetaiotaomicron)
PF10282
(Lactonase)
5 ALA A 193
ASP A 194
ILE A 184
VAL A 146
ILE A 144
None
0.83A 3jw2B-3fgbA:
undetectable
3jw2B-3fgbA:
13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g7r PUTATIVE
TRANSCRIPTIONAL
REGULATOR


(Streptomyces
coelicolor)
PF00440
(TetR_N)
6 GLY A 166
ALA A 167
VAL A  99
GLY A 186
VAL A  94
ILE A  98
None
None
None
None
None
EDO  A 960 ( 4.8A)
0.90A 3jw2B-3g7rA:
undetectable
3jw2B-3g7rA:
16.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gf7 GLUTACONYL-COA
DECARBOXYLASE
SUBUNIT A


([Clostridium]
symbiosum)
PF01039
(Carboxyl_trans)
6 LEU A 148
GLY A 191
ALA A 213
ASP A 212
GLY A 256
ILE A 189
None
1.20A 3jw2B-3gf7A:
undetectable
3jw2B-3gf7A:
11.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gh8 IODOTYROSINE
DEHALOGENASE 1


(Mus musculus)
PF00881
(Nitroreductase)
5 LEU A 256
GLY A 218
ILE A 116
GLY A 120
ILE A 190
None
0.79A 3jw2B-3gh8A:
undetectable
3jw2B-3gh8A:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gve YFKN PROTEIN

(Bacillus
subtilis)
PF00149
(Metallophos)
5 GLY A 121
ALA A 122
ASP A 123
ILE A  89
ILE A 126
None
0.53A 3jw2B-3gveA:
undetectable
3jw2B-3gveA:
15.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h0x 78 KDA
GLUCOSE-REGULATED
PROTEIN HOMOLOG


(Saccharomyces
cerevisiae)
PF00012
(HSP70)
6 LEU A 504
ASP A 535
GLY A 537
ILE A 470
VAL A 481
ILE A 507
None
1.36A 3jw2B-3h0xA:
undetectable
3jw2B-3h0xA:
19.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hhd FATTY ACID SYNTHASE

(Homo sapiens)
PF00109
(ketoacyl-synt)
PF00698
(Acyl_transf_1)
PF02801
(Ketoacyl-synt_C)
PF16197
(KAsynt_C_assoc)
6 LEU A 567
ALA A 590
ASP A 591
GLY A 579
ILE A 495
ILE A 564
None
1.36A 3jw2B-3hhdA:
undetectable
3jw2B-3hhdA:
8.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i5g MYOSIN HEAVY CHAIN
ISOFORM A


(Doryteuthis
pealeii)
PF00063
(Myosin_head)
PF00612
(IQ)
PF02736
(Myosin_N)
6 GLY A 264
ALA A 265
ASP A 266
GLY A 460
ILE A 459
ILE A 224
None
1.05A 3jw2B-3i5gA:
undetectable
3jw2B-3i5gA:
8.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3it4 ARGININE
BIOSYNTHESIS
BIFUNCTIONAL PROTEIN
ARGJ ALPHA CHAIN


(Mycobacterium
tuberculosis)
PF01960
(ArgJ)
6 LEU A  66
GLY A  92
ASP A  98
GLY A 131
ILE A 130
VAL A  65
None
1.48A 3jw2B-3it4A:
undetectable
3jw2B-3it4A:
16.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j7a 40S RIBOSOMAL
PROTEIN ES6


(Plasmodium
falciparum)
PF01092
(Ribosomal_S6e)
5 LEU H 111
GLY H  55
ILE H 101
GLY H 103
ILE H  52
None
G  A 160 ( 3.9A)
None
None
None
0.81A 3jw2B-3j7aH:
undetectable
3jw2B-3j7aH:
16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jv7 ADH-A

(Rhodococcus
ruber)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 LEU A 211
GLY A 216
ALA A 217
ASP A 218
ILE A 190
None
0.76A 3jw2B-3jv7A:
undetectable
3jw2B-3jv7A:
16.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jv7 ADH-A

(Rhodococcus
ruber)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 LEU A 211
GLY A 216
ALA A 217
ASP A 218
ILE A 200
None
0.84A 3jw2B-3jv7A:
undetectable
3jw2B-3jv7A:
16.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k6j PROTEIN F01G10.3,
CONFIRMED BY
TRANSCRIPT EVIDENCE


(Caenorhabditis
elegans)
PF00725
(3HCDH)
PF02737
(3HCDH_N)
6 LEU A 213
ALA A 200
VAL A 184
GLY A 148
VAL A 214
ILE A 186
None
None
None
None
PO4  A 501 (-4.0A)
None
1.47A 3jw2B-3k6jA:
undetectable
3jw2B-3k6jA:
12.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kiz PHOSPHORIBOSYLFORMYL
GLYCINAMIDINE
CYCLO-LIGASE


(Cytophaga
hutchinsonii)
PF02769
(AIRS_C)
5 GLY A  59
ASP A 161
ILE A 108
VAL A  77
ILE A  81
EDO  A 398 ( 3.8A)
None
ACT  A 394 ( 4.6A)
None
None
0.79A 3jw2B-3kizA:
undetectable
3jw2B-3kizA:
13.32